Chemoinformaics analysis of 1-(3-Methylbutyl)-2,3,5-trimethylbenzene
| Molecular Weight | 190.33 | nRot | 3 |
| Heavy Atom Molecular Weight | 168.154 | nRig | 6 |
| Exact Molecular Weight | 190.172 | nRing | 1 |
| Solubility: LogS | -6.055 | nHRing | 0 |
| Solubility: LogP | 5.7 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 38.0494 |
| nHD | 0 | BPOL | 22.0706 |
| QED | 0.67 |
| Synth | 1.974 |
| Natural Product Likeliness | 0 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.135 |
| Pgp-sub | 0.008 |
| HIA | 0.007 |
| CACO-2 | -4.559 |
| MDCK | 0.0000183 |
| BBB | 0.855 |
| PPB | 0.969647 |
| VDSS | 2.617 |
| FU | 0.0227397 |
| CYP1A2-inh | 0.412 |
| CYP1A2-sub | 0.914 |
| CYP2c19-inh | 0.756 |
| CYP2c19-sub | 0.914 |
| CYP2c9-inh | 0.554 |
| CYP2c9-sub | 0.871 |
| CYP2d6-inh | 0.177 |
| CYP2d6-sub | 0.894 |
| CYP3a4-inh | 0.363 |
| CYP3a4-sub | 0.333 |
| CL | 9.422 |
| T12 | 0.202 |
| hERG | 0.023 |
| Ames | 0.03 |
| ROA | 0.019 |
| SkinSen | 0.265 |
| Carcinogencity | 0.11 |
| EI | 0.992 |
| Respiratory | 0.028 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.676766 |